Booster vaccination protection against SARS-CoV-2 infections in young adults during an Omicron BA.1-predominant period: A retrospective cohort study.
<h4>Background</h4>While booster vaccinations clearly reduce the risk of severe Coronavirus Disease 2019 (COVID-19) and death, the impact of boosters on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections has not been fully characterized: Doing so requires understandi...
Κύριοι συγγραφείς: | Jiayue Wan, Casey L Cazer, Marin E Clarkberg, Shane G Henderson, Scarlett E Lee, Genevive R Meredith, Marwan Osman, David B Shmoys, Peter I Frazier |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
Public Library of Science (PLoS)
2023-01-01
|
Σειρά: | PLoS Medicine |
Διαθέσιμο Online: | https://doi.org/10.1371/journal.pmed.1004153 |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Heterologous booster vaccines reduce severity and mortality in COVID-19 during BA.2 and BA.4/BA.5 omicron predominance in Thailand
ανά: Kannikar Intawong, κ.ά.
Έκδοση: (2023-12-01) -
Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2
ανά: Maarten Swart, κ.ά.
Έκδοση: (2023-03-01) -
Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination
ανά: Rune M. Pedersen, κ.ά.
Έκδοση: (2022-06-01) -
Antimicrobial resistance among canine enterococci in the northeastern United States, 2007–2020
ανά: Marwan Osman, κ.ά.
Έκδοση: (2023-01-01) -
Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera
ανά: Xun Wang, κ.ά.
Έκδοση: (2022-10-01)